A S Lakha

1 ta ish

Oxford University Hospitals NHS Trust

1. Benefit of adjuvant chemotherapy for resected pancreatic cancer following neoadjuvant FOLFIRINOX or Gemcitabine-Nab-paclitaxel: a multinational analysis

   V Lopez-Lopez, Tanja Hasse, Philipp Houben +35

   MaqolaOAOchiq kirish20260 iqtibos

   ABIABI:AkademIndex/2026.article.038474